17 results
Keyword Dzuveo Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Dzuveo
sufentanil citrate, Pain
Date of authorisation: 25/06/2018, Revision: 6, Authorised, Last updated: 31/03/2023Dzuveo Pathological Conditions … thorised sufentanil Overview Dzuveo is an opioid pain medicine … between the products is that Dzuveo is available as sublingual … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 April 2018
CHMP, Last updated: 27/04/2018Dzuveo … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 31/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 23/01/2023 to 26/01/2023, Last updated: 14/04/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/11/2022 to 10/11/2022, Last updated: 10/01/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 27/11/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022
PRAC, Last updated: 08/07/2022 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 09/01/2023 to 12/01/2023, Last updated: 18/08/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018
European Medicines Agency, London, UK, from 23/04/2018 to 26/04/2018, Last updated: 08/06/201813 3.1.4. Dzuveo - sufentanil - EMEA/H/C/004335 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023
PRAC, Last updated: 13/01/2023 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 10/11/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 28-31 May 2018
European Medicines Agency, London, UK, from 28/05/2018 to 31/05/2018, Last updated: 06/01/2014 -
List item
Public data from Article 57 database
Last updated: 09/10/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 18/07/2022 to 21/07/2022, Last updated: 06/04/2021 -
List item
Newsletter archive
Last updated: 20/10/2015 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020